-transparent.png){kind=logo}
In the United States in 1996, there were an estimated 10,190 aspergillosis-related hospitalizations (95% confidence interval [CI], 9000-11,380); these resulted in 1970 deaths (95% CI, 1659-2280), 176,272 hospital days (95% CI, 147,163-206,275), and $633.1 million in costs (95% CI, $492.0-$780.2 million). The average hospitalization lasted 17.3 days (95% CI, 16.1-18.6) and cost $62,426 (95% CI, $52,670-$72,181). Although aspergillosis-related hospitalizations account for a small percentage of hospitalizations in the United States, patients hospitalized with the condition have lengthy hospital stays and high mortality rates.
Related Publications
E J Dasbach, and
G M Davies, and
S M Teutsch
May 2019,
BMC public health,
E J Dasbach, and
G M Davies, and
S M Teutsch
April 2021,
JAMA oncology,
E J Dasbach, and
G M Davies, and
S M Teutsch
January 2017,
Open forum infectious diseases,
E J Dasbach, and
G M Davies, and
S M Teutsch
September 2025,
Mycoses,
E J Dasbach, and
G M Davies, and
S M Teutsch
September 2016,
International journal of environmental research and public health,
E J Dasbach, and
G M Davies, and
S M Teutsch
May 2015,
The American journal of medicine,
E J Dasbach, and
G M Davies, and
S M Teutsch
July 2015,
Journal of clinical gastroenterology,
E J Dasbach, and
G M Davies, and
S M Teutsch
December 2004,
American journal of preventive medicine,
E J Dasbach, and
G M Davies, and
S M Teutsch
November 2007,
The American journal of medicine,
E J Dasbach, and
G M Davies, and
S M Teutsch
February 2018,
Chest,
